Morbidity and Mortality Weekly Report

A study on COVID-19 vaccine effectiveness, initially blocked from publication in a CDC journal, was published in JAMA Network Open. The study found vaccines reduced hospitalizations by 55% and emergency/urgent care visits by 50%, using a methodology criticized by CDC acting director Jay Bhattacharya but defended by public health researchers.

A study on the effectiveness of the COVID-19 vaccine, initially blocked from publication in a CDC journal, found the vaccine to be 55% effective against hospitalizations and 50% effective against emergency department/urgent care visits. The study, published in JAMA Network Open, used a test-negative design methodology, which CDC acting director Jay Bhattacharya criticized for potential flaws, though public health researchers defend its reliability.

The article claims the CDC promoted mask-wearing during COVID using low-quality research, citing a study by Vinay Prasad and Tracey Beth Hoeg. Their analysis found 77 CDC studies on masks published after 2019, with 30% lacking comparative groups and none being randomized trials, suggesting flawed evidence.

A study in the Morbidity and Mortality Weekly Report details a severe Texas measles outbreak, showing 20% hospitalization rates, contradicting anti-vaccine claims that measles is 'just a rash.' Declining vaccination rates linked to rising anti-vaccine rhetoric, including from Robert F. Kennedy Jr., have fueled large outbreaks of preventable diseases.

The acting head of the CDC blocked the publication of a study on the effectiveness of COVID-19 vaccines, as confirmed by an HHS spokesperson. The study was scheduled for release in the CDC's Morbidity and Mortality Weekly Report (MMWR) on March 19.

Antibiotic-resistant Shigella infections have increased substantially in the U.S. from 2011 to 2023, with 8.5% of cases resistant to common antibiotics by 2023. The CDC reported findings in its Morbidity and Mortality Weekly Report, highlighting the spread of drug-resistant strains within the U.S. and the lack of FDA-approved treatments for resistant cases.

A CDC study highlighting significant health benefits from this season's COVID-19 vaccines was blocked from publication by acting CDC director Jay Bhattacharya. The move is attributed to Health Secretary Robert F. Kennedy Jr., an anti-vaccine advocate, raising concerns about political interference in scientific processes.